184 related articles for article (PubMed ID: 8777973)
1. Pulmonary dysfunction in cystic fibrosis is associated with oxidative stress.
Brown RK; Wyatt H; Price JF; Kelly FJ
Eur Respir J; 1996 Feb; 9(2):334-9. PubMed ID: 8777973
[TBL] [Abstract][Full Text] [Related]
2. Treatment of pulmonary exacerbations of cystic fibrosis leads to improved antioxidant status.
Range SP; Dunster C; Knox AJ; Kelly FJ
Eur Respir J; 1999 Mar; 13(3):560-4. PubMed ID: 10232426
[TBL] [Abstract][Full Text] [Related]
3. Reduced free-radical-trapping capacity and altered plasma antioxidant status in cystic fibrosis.
Langley SC; Brown RK; Kelly FJ
Pediatr Res; 1993 Mar; 33(3):247-50. PubMed ID: 8460060
[TBL] [Abstract][Full Text] [Related]
4. Evidence for increased oxidative damage in patients with cystic fibrosis.
Brown RK; Kelly FJ
Pediatr Res; 1994 Oct; 36(4):487-93. PubMed ID: 7816524
[TBL] [Abstract][Full Text] [Related]
5. Oxidative stress during acute respiratory exacerbations in cystic fibrosis.
McGrath LT; Mallon P; Dowey L; Silke B; McClean E; McDonnell M; Devine A; Copeland S; Elborn S
Thorax; 1999 Jun; 54(6):518-23. PubMed ID: 10335006
[TBL] [Abstract][Full Text] [Related]
6. Improved antioxidant and fatty acid status of patients with cystic fibrosis after antioxidant supplementation is linked to improved lung function.
Wood LG; Fitzgerald DA; Lee AK; Garg ML
Am J Clin Nutr; 2003 Jan; 77(1):150-9. PubMed ID: 12499335
[TBL] [Abstract][Full Text] [Related]
7. Longitudinal study of oxidative status in 312 cystic fibrosis patients in stable state and during bronchial exacerbation.
Lagrange-Puget M; Durieu I; Ecochard R; Abbas-Chorfa F; Drai J; Steghens JP; Pacheco Y; Vital-Durand D; Bellon G
Pediatr Pulmonol; 2004 Jul; 38(1):43-9. PubMed ID: 15170872
[TBL] [Abstract][Full Text] [Related]
8. Total plasma antioxidant capacity in cystic fibrosis.
Lands LC; Grey VL; Grenier C
Pediatr Pulmonol; 2000 Feb; 29(2):81-7. PubMed ID: 10639197
[TBL] [Abstract][Full Text] [Related]
9. Increased plasma fatty acid concentrations after respiratory exacerbations are associated with elevated oxidative stress in cystic fibrosis patients.
Wood LG; Fitzgerald DA; Gibson PG; Cooper DM; Garg ML
Am J Clin Nutr; 2002 Apr; 75(4):668-75. PubMed ID: 11916752
[TBL] [Abstract][Full Text] [Related]
10. Plasma vitamin C concentrations in patients with cystic fibrosis: evidence of associations with lung inflammation.
Winklhofer-Roob BM; Ellemunter H; Frühwirth M; Schlegel-Haueter SE; Khoschsorur G; van't Hof MA; Shmerling DH
Am J Clin Nutr; 1997 Jun; 65(6):1858-66. PubMed ID: 9174484
[TBL] [Abstract][Full Text] [Related]
11. Antioxidant supplementation for lung disease in cystic fibrosis.
Ciofu O; Lykkesfeldt J
Cochrane Database Syst Rev; 2014 Aug; (8):CD007020. PubMed ID: 25102015
[TBL] [Abstract][Full Text] [Related]
12. Enhanced oxidative damage in cystic fibrosis patients.
Domínguez C; Gartner S; Liñán S; Cobos N; Moreno A
Biofactors; 1998; 8(1-2):149-53. PubMed ID: 9699024
[TBL] [Abstract][Full Text] [Related]
13. Is an FEV
König P; Ner Z; Acton JD; Ge B; Hewett J
Clin Respir J; 2018 Aug; 12(8):2397-2403. PubMed ID: 29920961
[TBL] [Abstract][Full Text] [Related]
14. Pulmonary function and clinical course in patients with cystic fibrosis after pulmonary colonization with Pseudomonas aeruginosa.
Kerem E; Corey M; Gold R; Levison H
J Pediatr; 1990 May; 116(5):714-9. PubMed ID: 2109790
[TBL] [Abstract][Full Text] [Related]
15. Oxidative damage to DNA in patients with cystic fibrosis.
Brown RK; McBurney A; Lunec J; Kelly FJ
Free Radic Biol Med; 1995 Apr; 18(4):801-6. PubMed ID: 7750803
[TBL] [Abstract][Full Text] [Related]
16. Vitamins A and E and pulmonary exacerbations in patients with cystic fibrosis.
Hakim F; Kerem E; Rivlin J; Bentur L; Stankiewicz H; Bdolach-Abram T; Wilschanski M
J Pediatr Gastroenterol Nutr; 2007 Sep; 45(3):347-53. PubMed ID: 17873748
[TBL] [Abstract][Full Text] [Related]
17. Comparison among pulmonary function test results, the Shwachman-Kulczycki score and the Brasfield score in patients with cystic fibrosis.
Freire ID; Abreu E Silva FA; Araújo MA
J Bras Pneumol; 2008 May; 34(5):280-7. PubMed ID: 18545823
[TBL] [Abstract][Full Text] [Related]
18. Plasma antioxidants in pediatric patients with glycogen storage disease, diabetes mellitus, and hypercholesterolemia.
Wittenstein B; Klein M; Finckh B; Ullrich K; Kohlschütter A
Free Radic Biol Med; 2002 Jul; 33(1):103-10. PubMed ID: 12086688
[TBL] [Abstract][Full Text] [Related]
19. Antioxidant deficiency in cystic fibrosis: when is the right time to take action?
Back EI; Frindt C; Nohr D; Frank J; Ziebach R; Stern M; Ranke M; Biesalski HK
Am J Clin Nutr; 2004 Aug; 80(2):374-84. PubMed ID: 15277158
[TBL] [Abstract][Full Text] [Related]
20. Consequences of Expiratory Flow Limitation at Rest in Subjects with Cystic Fibrosis.
Vilozni D; Lavie M; Ofek M; Sarouk I; Bar-Aluma BE; Dagan A; Ashkenazi M; Segel MJ; Efrati O
Ann Am Thorac Soc; 2016 Jun; 13(6):825-32. PubMed ID: 27219817
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
